Stuart Evan Seropian MD

Associate Professor of Medicine (Hematology and FY15 Hematology)

Clinical Interests

Hodgkin's disease; Non-Hodgkin's Lymphoma (NHL); multiple myeloma; bone marrow transplant; stem cell transplant


Board Certifications

1997
Medical Oncology, Board Certified

Patient Care Locations

 
stuart_seropianfaculty-clinicsfalsetruetrue6truefalsefalse
 

Clinical Trials

Conditions Study Title
Hepatic Veno-Occlusive Disease Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
Hepatic Veno-Occlusive Disease, Hodgkin's Lymphoma, Leukemia, not otherwise specified, Multiple Myeloma, and Non-Hodgkin's Lymphoma Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study
Limited-stage Diffuse Large B-Cell Lymphoma and Non-Hodgkin's Lymphoma A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (SWOG S1001)
Myeloid and Monocytic Leukemia E2905: Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid) Alone and in Combination with Epoetin Alfa (Procrit) in Subjects with Low- or Intermediate-1 Risk MDS and Symptomatic Anemia
Leukemia, not otherwise specified and Myeloid and Monocytic Leukemia An Open Label, Phase I/IIa, Dose Escalation Trial to Investigate the Maximum Tolerated Dose, Safety, Pharmacokinetics, and Efficacy of Intravenous Volasertib (BI 6727) in Combination with Decitabine in Patients with Acute Myeloid Leukemia

More Clinical Trials...

Edit Profile